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PERSPECTIVE
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Abstract
Apathy, gait disturbances, and executive dysfunction (AGED) often occur together.
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Although they can arise independently, the presence of one might portend another.
This recognition suggests the possible etiology. We focus on the most common, the vas-
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cular. We explain the AGED vascular mechanism through the ambibaric brain concept.
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Homo sapiens brain (cerebral hemispheres). Hypertension inflicts the most damage on
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The brain contains two complementary blood pressure systems: One high in the primitive brain (brainstem, basal ganglia, and thalamus) and a low-pressure system in the
the primitive brain. The frontal systems connect to the basal ganglia, then the thalamus
and back to the cortex. Many connections converge on the primitive brain where they
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are damaged by vascular disease. We need methods of determining optimal, individual
blood pressures. Although the AGED triad can result from other causes, it should first
signal a vascular etiology, the most prevalent, treatable, and preventable one.
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INTRODUCTION

years, 9.1% between 70 and 79 years, and 13.5% in the decade from 80
to 89 years.

Apathy, gait impairment, and diminished executive function often occur

The association of executive dysfunction and gait disorders is well

together, but usually are considered apart. However, an aging pheno-

established.1 More recently, it has been shown that hypertension is the

type of slow gait, impaired executive function, and depressive symp-

main cause of brain small vessel disease that can lead to apathy.5 Thus

toms has been described1

the combination of “think slow, walk slow, and feel slow” could be con-

and associated with hypertension and other

cardiovascular diseases. In a subset of late life depression patients, this

veyed as apathy, gait impairment, and executive dysfunction (the AGED

triad was found in 99 of 580 (17%) healthy, nondemented, community-

triad).

dwelling seniors, aged 70 years or older.1 Mehta et al. found that rel-

Although the exact mechanisms relating hypertension to these

ative to younger elderly (65–80 years), apathy becomes more com-

three impairments are not fully known, their co-occurrence can

mon in old elderly (>80 years).2 We examined the prevalence of execu-

be explained by an evolutionary interpretation of the cerebral

tive dysfunction, gait impairment, and apathy in a clinic-based cohort

circulation—the ambibaric brain.6 The most primitive brains consist

of community-dwelling older adults free of depression at baseline in

of a tube with an enlarged end—the brain. They are supplied by a

the Gait and Brain Study (design and methods have been described in

basal artery giving off short, perpendicular end arteries. This pattern

detail elsewhere).3 Tables 1 and 2 show that apathy, gait impairment,

is preserved in humans in the brainstem, the basal ganglia, and the

and executive dysfunction were present in 4.3% in the decade 60 to 69

thalamus—the primitive brain. The pressure from the basal arterial
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trunk must be stepped down to capillary pressure over a relatively
short segment. If a person develops hypertension, the penetrating

RESEARCH IN CONTEXT

arteries have to contract harder to maintain a constant blood supply.
This often results in hypertrophy of the muscular layer and at times
hyalinosis and microaneurysms, with a propensity for occlusions, causing lacunar infarcts or ruptures resulting in intracerebral hemorrhages.
The human (Homo sapiens) brain is characterized by the massive
expansion of the hemispheres, largely supplied by long branching arteries giving off arterioles penetrating the hemispheres. The long arteries allow for a gradual stepping down of the arterial blood pressure to
capillary pressure. Consequently, the human brain effectively has two
complementary pressure systems. A high one in the primitive brain and
a low one in the Homo sapiens brain. Modeling suggests that when the
blood pressure in the arm is 115/75, it is 113/73 in the primitive brain
and 58/36 in parietal branches of the Homo sapiens brain.7
The brunt of hypertension damage occurs in the primitive brain.
Already in middle age, hypertension is associated with white matter
disruption and executive dysfunction that often occurs together with
gait impairment and depression.8,9
The architecture of all the frontal systems is similar: A part of the
frontal cortex connects to the basal ganglia, that project to the thalamus, that in turn connects back to the originating frontal cortex.
One explanation for the common association of AGED could be that
most of the relevant brain networks are damaged, because they go

1. Systematic review: Apathy, a gait impairment, and executive dysfunction (AGED) commonly occur jointly in the
elderly, sometimes masked by the generic description of
“late life depression.” The recognition of the triad is clinically useful because it often results from hypertension,
which is treatable and preventable.
2. Interpretation: When the AGED triad occurs with hypertension, it becomes important to realize that blood pressure in the brain is not uniform and treatment needs to
be customized. Studies suggest the desirability of lower
systolic blood pressure targets, as low as 120 mmHg.
Although on average this could be advisable, patients
with limited cerebral blood flow autoregulation might be
harmed.
3. Future directions: Given the high prevalence of hypertension, co-morbidities, and polypharmacy among the
elderly, developing non-invasive methods of assessing
autoregulation becomes imperative, so that the optimal
blood pressure for each individual can be prescribed. This
could be one of the highest priorities in personalized
medicine.

through the primitive brain. A common cause is hypertension that can
lead to infarcts and hemorrhages. These might be preceded by damage
to the pericytes controlling capillary blood flow (Figure 1).
Executive functions are mainly subserved by brain networks arising
in the lateral prefrontal cortex; gait control by the prefrontal–striatal
networks;10 and apathy, through damage to connections of the ante-

ever, fluctuations of blood pressure and acute hypotension can harm

rior cingulate, with the ventral striatum.11

the brain.
All clinical trials are selective and exclude patients who might
have complicating conditions, such as diabetes, that may impair cere-

2

DISCUSSION

bral blood flow autoregulation. Consequently, if the new recommendations are to be applied widely, we need to know the individual

Although hypertension is a common culprit, the AGED triad can also

brain autoregulatory capacity. This becomes particularly important in

result from other causes such as neurodegeneration, notably in fron-

patients with multimorbidities and those taking multiple drugs. Multi-

totemporal dementias, Parkinson’s disease, or brain trauma. However,

ple medical conditions lead to multiple drugs being prescribed, some

in these conditions it is usually preceded or overshadowed by other

with unintended consequences. Decongestants and nonsteroidal anti-

symptoms such as behavioral disorders in frontotemporal dementia,

inflammatory drugs can increase blood pressure and sleeping pills can

slowing and masking in Parkinson’s disease, and memory impairment

decrease blood pressure. Therefore, one of the greatest needs of per-

or emotion dysregulation in head trauma.

sonalized medicine is to develop non-invasive techniques to assess

The importance of the thinking of an AGED triad stems from the fact

cerebral blood flow autoregulation, so that the optimal level of blood

that the presence of one component should raise awareness of the risk

pressure for the brain could be individualized. For instance, a pheno-

of developing another and point to an underlying treatable cause, such

type of dual-decliners, older adults who experience concurrent decline

as hypertension. A number of studies suggest the benefits of inten-

in gait speed and cognition (mainly memory and executive functions),

sive blood pressure reduction.12–15 Treating hypertension is one way

has been associated with a higher risk to progress to dementia, as

to prevent small vessel disease and the subsequent cognitive impair-

hypertension is a main risk factor associated with this phenotype.16,17

ment in executive function.15

Mechanistically, this supports the poten-

Early recognition of those experiencing the dual decline in gait speed

tial that hypertension treatment may also prevent or delay gait decline

and cognition can point to those older adults at higher risk of demen-

and apathy and prevent the AGED triad. The SPRINT Trial13 results

tia who might benefit the most from a carefully personalized intensive

even suggested lowering blood pressure targets to 120 mmHg. How-

hypertension treatment.
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AGED triad prevalence and baseline characteristics in the Gait and Brain Study
Full cohort

AGED triad–

AGED triad+

Mean ± SD or n,%;
min–max N = 370

Mean ± SD or n,%;
min–max N = 341

Mean ± SD or n,%;
min–max N = 29

Age in years

72.1 ± 6.7; 59–92

71.8 ± 6.6; 59–92

75.6 ± 7; 60–89

Women n,%

270, 58

201, 58

15, 51

Number of years of
education

14.6 ± 3.1; 6–25

14.8 ± 3.1; 6–25

12.9 ± 2.7; 6–19

Body mass index
(kg/cm2 )

28 ± 5.4; 17.8–51.5

28 ± 5.5; 17.8–51.5

28.2 ± 4.1;
23.2–40.8

MMSE (range 0–30)

27.5 ± 2.2; 18–30

27.6 ± 2.1; 18–30

26.5 ± 2.9; 18–30

Eta-squared
.023
<.001

P value
.004
.45

.024

.003

<.001

.858

.018

.009

MoCA (range 0–30)

24.5 ± 3.5; 12–30

24.7 ± 3.4; 12–30

22.5 ± 3.4; 16–29

.029

.001

GDS (range 0–15)

2.4 ± 2.6; 0–13

2.1 ± 2.5; 0–13

5.4 ± 2.5; 3–12

.111

<.001

Trail Making Test A
(seconds)

39.3 ± 15.4; 9–110

38.1 ± 14.7; 9–110

53.9 ± 16.3;
26–99.12

.077

<.001

Trail Making Test B
(seconds)

118.1 ± 169.9; 9–300

111.8 ± 174.1; 9–300

191.9 ± 76.6;
127–444.2

.016

.015

Digit span Forward
(range 0–16)

10 ± 2.2; 5–16

10 ± 2.2; 5–16

9.6 ± 2.2; 6–16

.003

.333

Digit span Backward
(range 0–14)

6.2 ± 2; 1–13

6.3 ± 2.1; 1–13

5.3 ± 1.8; 2–10

.016

.015

RAVLT immediate
recall (range 0–15)

7 ± 3.9; 0–15

7.1 ± 3.9; 0–15

5.3 ± 3.2; 0–11

.015

.018

PASE

117.4 ± 59.6; 5–415.2

120 ± 59.8; 5–415.2

86.1 ± 48.5;
25–196.8

.023

.003

SPPB (range 0–12)

9.7 ± 2.1; 2–17

9.9 ± 2; 3–17

7.4 ± 2.6; 2–12

.093

<.001

Total number of
medications taken

6.9 ± 4.3; 0–24

6.7 ± 4.3; 0–24

8.6 ± 4.2; 0–17

.014

.024

Lawton–Brody IADL
score

7.8 ± 0.6; 2–8

7.8 ± 0.5; 2–8

7.2 ± 1.4; 3–8

.062

<.001

Frailty score (range
0–5)a

1.1 ± 1.1; 0–4

1 ± 1; 0–4

2.7 ± 0.9; 1–4

.132

<.001

Grip strengthb (kg/N)

26.5 ± 10.4; 1–88.6

26.7 ± 10.5; 6.3–88.6

23.5 ± 9.4; 1–44.3

.006

.187

Number of falls in past
year

0.6 ± 1.3; 0–12

0.5 ± 1; 0–6

1.9 ± 2.9; 0–12

.074

<.001

Number of falls in past
6 months

0.4 ± 1; 0–12

0.3 ± 0.6; 0–3

1.7 ± 2.7; 0–12

.136

<.001

Usual gait speed (cm/s)

113.9 ± 22.6;
32.28–179

115.9 ± 21.4;
49.12–179

90.7 ± 23.8;
32.28–144.3

.091

<.001

Counting gait speed
(cm/s)

108.8 ± 26.1;
22.43–186.5

111 ± 25.1;
37.5–186.5

82.7 ± 23.8;
22.43–131.0

.085

<.001

Naming animals gait
speed (cm/s)

100.9 ± 27.3;
28.05–172.8

102.9 ± 26.7;
41.24–172.8

77.1 ± 24.2;
28.05–118.9

.063

<.001

Serial 7 s gait speed
(cm/s)

97 ± 27.3;
21.72–180.0

99.1 ± 26.6;
31.92–180.08

73.3 ± 24.7;
21.72–125.7

.065

<.001

Note: AGED triad is defined as (1) having slow gait speed - < 1 m/s-; apathy by scoring ≥2 in the GDS-3A scale4 and having executive dysfunction and the
highest quartile in TMT B.
Abbreviations: AGED, apathy, gait disturbances, and executive dysfunction; GDS, Geriatric Depression Scale; IADL, Instrumental Activities of Daily Living;
MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; PASE, Physical Activity Scale for the Elderly; RAVLT, Rey Auditory Verbal
Learning Test; SD, standard deviation; SPPB, Short Physical Performance Battery.
a
Frailty score calculated from five items: weakness, exhaustion, low physical activity, unintentional weight loss of at least 10 lb in 1 year and slow gait.
b
Grip strength: average of three trials.
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F I G U R E 1 High-density circuits subserving of apathy, gait control, and executive function in brain regions prone to hypertension-mediated
injury. Solid lines represent efferent pathways and dashed lines afferent pathways

TA B L E 2

AGED triad + per age decade prevalence

Age decade range

AGED triad + n,%

60–69 (N = 141)

6, 4.3

70–79 (N = 175)

16, 9.1

80–89 (N = 52)

7, 13.5

Abbreviation: AGED, apathy, gait disturbances, and executive dysfunction.
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CONCLUSION

The concept of the ambibaric brain (complementary high and low brain
blood pressure systems) explains the vascular variant of the AGED
triad. Its recognition can point to underlying treatable conditions such
as hypertension, and to a cautious management of blood pressure fluctuations, including postural hypotension, in older adults. Future clinical
trials assessing the effect of treating hypertension on these neurogeriatric impairments are needed to identify early interventions that prevent disability in these individuals.
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